Gateway to Growth: Innovation and Opportunity at the 8th China International Import Expo (CIIE)
ByAinvest
Monday, Sep 1, 2025 12:10 pm ET1min read
BSX--
Novartis, a prominent pharmaceutical company, is one of the key players at the 8th CIIE. At the 4th CIIE, Novartis debuted Radioligand Therapy (RLT), a cutting-edge medical innovation. Leveraging the spillover effect of the CIIE, Novartis signed strategic partnerships with three Chinese partners—GE Healthcare China, Shanghai Pharmaceutical Holding, and Chongqing Pharmaceutical Holding—at the 7th CIIE. These collaborations have facilitated the speedy launch and expansion of RLT in China [1].
Boston Scientific is another company that has seen its products move from the expo floor to the market. Several of its products, which were showcased at the 7th CIIE, have successfully entered the Chinese market. Johnson & Johnson, expanding its booth to 700 square meters this year, will feature the MONARCH surgical robot and the lung cancer therapy Rukobia® at the 8th CIIE [1].
In parallel with the 8th CIIE, the Hongqiao International Economic Forum (HQF) is set to take place. The 8th HQF, with the theme "Opening Up for New Opportunities, Collaborating for a Shared Future," will feature more than 20 sessions on topics such as cooperation, innovation, development, and sharing. This year's forum will see active participation from international bodies like UNICEF and UNIDO, alongside government officials and industry leaders. The release of the World Openness Report 2025 will be a key highlight of the 8th HQF, emphasizing its role as a platform for global dialogue and collaboration [1].
The 8th CIIE offers unparalleled opportunities for businesses to connect, innovate, and grow. For those interested in participating, the latest updates and details can be found at [https://www.ciie.org/zbh/en/](https://www.ciie.org/zbh/en/) [1].
References:
[1] https://www.businesswire.com/news/home/20250901129755/en/Gateway-to-Growth-Innovation-and-Opportunity-at-the-8th-CIIE
NVS--
The China International Import Expo (CIIE) is set to showcase innovation, foster cooperation, and expand access to the Chinese market for global enterprises. The 8th CIIE will feature exhibits that have successfully entered the market after their debut at previous expos, including medical innovations from companies like Novartis and Boston Scientific. The Hongqiao International Economic Forum will also take place, focusing on themes like opening up for cooperation, innovation, development, and sharing.
The China International Import Expo (CIIE) is set to showcase innovation, foster cooperation, and expand access to the Chinese market for global enterprises. The 8th CIIE, scheduled to take place in Shanghai, promises to be a pivotal event in the global economic landscape. This year's expo will feature exhibits that have successfully transitioned from debuts at previous expos into marketable goods, underscoring the CIIE's role in driving market growth and innovation.Novartis, a prominent pharmaceutical company, is one of the key players at the 8th CIIE. At the 4th CIIE, Novartis debuted Radioligand Therapy (RLT), a cutting-edge medical innovation. Leveraging the spillover effect of the CIIE, Novartis signed strategic partnerships with three Chinese partners—GE Healthcare China, Shanghai Pharmaceutical Holding, and Chongqing Pharmaceutical Holding—at the 7th CIIE. These collaborations have facilitated the speedy launch and expansion of RLT in China [1].
Boston Scientific is another company that has seen its products move from the expo floor to the market. Several of its products, which were showcased at the 7th CIIE, have successfully entered the Chinese market. Johnson & Johnson, expanding its booth to 700 square meters this year, will feature the MONARCH surgical robot and the lung cancer therapy Rukobia® at the 8th CIIE [1].
In parallel with the 8th CIIE, the Hongqiao International Economic Forum (HQF) is set to take place. The 8th HQF, with the theme "Opening Up for New Opportunities, Collaborating for a Shared Future," will feature more than 20 sessions on topics such as cooperation, innovation, development, and sharing. This year's forum will see active participation from international bodies like UNICEF and UNIDO, alongside government officials and industry leaders. The release of the World Openness Report 2025 will be a key highlight of the 8th HQF, emphasizing its role as a platform for global dialogue and collaboration [1].
The 8th CIIE offers unparalleled opportunities for businesses to connect, innovate, and grow. For those interested in participating, the latest updates and details can be found at [https://www.ciie.org/zbh/en/](https://www.ciie.org/zbh/en/) [1].
References:
[1] https://www.businesswire.com/news/home/20250901129755/en/Gateway-to-Growth-Innovation-and-Opportunity-at-the-8th-CIIE
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet